FDA Recent Drug Recalls

Hospira

Recently Posted Drug Recalls From The FDA (Food and Drug Administration) “Drug recalls are actions taken by a firm to remove a product form the market.  Recalls may be conducted on a firm’s own initiative, by FDA request, or by FDA order under statutory authority.  In July 2011, FDA began a pilot program to notify [...]

Transvaginal Mesh Complications

Transvaginal Surgical Mesh | The Maher Law Firm

There may be a Transvaginal Mesh recall to prevent future damages The FDA (Food and Drug Administration) is reviewing thousands of transvaginal mesh injury cases, including severe injury and death cases. Doctors from across the country testified before the Food and Drug Administration’s Obstetrics and Gynecology Device Advisory Committee in September 2011 in regards to [...]

Januvia | Type Two Diabetes

Januvia is a pill taken once a day to help lower blood sugar levels in adults with type two diabetes. Januvia works by increasing the insulin made by your pancreas when blood sugar is high, and by reducing the amount of sugar made by your liver. Between October 2006 and February 2009, the FDA (Food [...]

Actos

actos | The Maher Law Firm

What Is Actos? Actos is a prescription diabetes medication distributed by Japan-based Takeda Pharmaceuticals Company Ltd., it’s active ingredient is, “Pioglitazone Hydrochloride”, it is used to help improve blood sugar control in adults with type two diabetes.  Actos helps your body better use the insulin it makes and by stopping your liver from making sugar that [...]

Hidden Ingredient found in Weight Loss Drug

Maxiloss weight advanced | The Maher Law Firm | Frank Eidson

Maxiloss Weight Advanced – Found to contain hidden drug ingredient FDA (Food & Drug Administration) laboratory analysis confirmed that MAXILOSS Weight Advanced contains sibutramine.  Sibutramine was removed from the market in October of 2010 due to its ability to substantially increases blood pressure and/or pulse rate in some patients.  Also, it  may present a significant [...]

Compounding Pharmacies

Compounding Pharmacies | The Maher Law Firm

Compounding Pharmacies, regulation and the U.S. Food and Drug Administration Compounding pharmacies make custom medications for patients in response to a prescription, which are then overseen by the state boards of pharmacy. Fueled by the tainted spinal injection, manufactured by the NECC – New England Compounding Center, and resulting in a fungal meningitis outbreak;  causing [...]

Pancreatic Cancer | Januvia | Byetta

Januvia | Byetta | The Maher Law Firm

Januvia and Byetta may increase the risk of pancreatic cancer Januvia – a prescription pill that helps lower blood sugar levels in adults with type 2 diabetes. Byetta – an injectable prescription medication that helps improve blood sugar levels in adults with type 2 diabetes. In September of 2009 the FDA (Food and Drug Administration) [...]

Xyrem

xyrem

Xyrem manufacturer – Jazz Pharmaceuticals – issues new box warning Jazz Pharmaceuticals has put a new boxed warning label on Xyrem -a type of Gamma Hydroxbutyrate – GHB – (a drug with sedative hypnotic effects, originally developed as a pre-surgery anaesthetic) used to treat excessive daytime sleepiness and cataplexy, both in patients with narcolepsy. A [...]

Atorvastatin

Atorvastatin | Lipitor | Generic Lipitor | The Maher Law Firm | Frank Eidson Attorney At Law

Lipitor’s generic equivalent, Atorvastatin, might contain specks of glass Ranbaxy Pharmaceuticals, Atorvastatin’s manufacturer, initiated the recall on November 9th, telling pharmacies to stop dispensing the cholesterol lowering drug due to the possibility of glass specks in the medication. The FDA (Food and Drug Administration) advised patients to stop taking atorvastatin medicine if their pharmacist confirmed [...]

Johnson & Johnson’s Drug Risperdal Causes Breast Growth In Men

risperdal

Risperdal was improperly marketed by Johnson & Johnson Johnson & Johnson settles a lawsuit over claims that it’s anti-psychotic drug “Risperdal” caused a male plaintiff to grow breast tissue. Janssen, a unit of Johnson & Johnson, faces 420 lawsuits brought against the company alleging personal injuries caused by Risperdal.  Almost 130 of the 420 lawsuits [...]